Biotech

OXGENE Seeks to Overcome Challenges in Gene Therapy Production

OXGENE, a WuXi Advanced Therapies company, hopes to pioneer a new frontier in Gene Therapy GMP manufacturing.

The Science Behind the 2023 Nobel Prize for Medicine Winners

Katalin Karikó and Drew Weissman accept the 2023 Nobel Prize in Physiology or Medicine.

Verve Therapeutics Halts Gene Editing Trial After Side Effects

Verve halts enrollment in lead trial following grade 3 side effects and prioritizes next steps for PCSK9 editing therapy.

Hit-and-run Epigenome Editing: Gene Therapy Advancements

This study introduces a groundbreaking genetic engineering approach with immense potential for precision medicine.

Advancements in Genome Editing: Zinc-Finger Conditioned Recombinases

New technology promises a safer and more precise way of treating genetic disorders.

Development in Synthetic Biology for Safe and Controlled CAR-T Cell Therapy

Explore the revolutionary developments in Synthetic Biology for enhancing the safety and control of CAR-T cell therapy.